Skip Nav Destination
1-20 of 179
Keywords: Inflammatory bowel diseaseClose
Mira M. Yang, Keith Usiskin, Harris A. Ahmad, Shabana Ather, Antoine Sreih, James B. Canavan, Francis A. Farraye, Christopher Ma
Dig Dis 1–13.
Published Online: 27 September 2023
...Mira M. Yang; Keith Usiskin; Harris A. Ahmad; Shabana Ather; Antoine Sreih; James B. Canavan; Francis A. Farraye; Christopher Ma Background: High-quality colonoscopic surveillance can lead to earlier and increased detection of colorectal neoplasia in patients with inflammatory bowel disease (IBD...
Dominika Boldovjakova, Islam El-Abbassy, Inari Alarcon, Mamoun El-Saify, Juen Hao Chan, Morag Harley, Craig Parnaby, Angus Watson, George Ramsay
Dig Dis 1–7.
Published Online: 08 September 2023
...Dominika Boldovjakova; Islam El-Abbassy; Inari Alarcon; Mamoun El-Saify; Juen Hao Chan; Morag Harley; Craig Parnaby; Angus Watson; George Ramsay Introduction: Inflammatory bowel disease (IBD) often requires surgical resection, such as subtotal colectomy operations to alleviate symptoms. However...
Dig Dis (2023) 41 (4): 656–665.
Published Online: 04 July 2023
...Adam Saleh; Shyon Parsa; Manuel Garza; Eamonn M.M. Quigley; Bincy P. Abraham Background: Considerable research supports an important role for the microbiome and/or microbiome-host immune system interactions in the pathogenesis of inflammatory bowel disease (IBD). Consequently, microbiota-modulating...
Ida Normiha Hilmi, Nik Arsyad Nik Muhamad Affendi, Shahreedhan Shahrani, Abdul Malik Thalha, Alex Hwong-Ruey Leow, Xin-Hui Khoo
Dig Dis (2023) 41 (4): 581–588.
Published Online: 04 July 2023
... to in the content or advertisements. 2023 Intestinal tuberculosis Crohn’s disease Standardized algorithm Inflammatory bowel disease Crohn’s disease (CD) is an emerging disease in the Asia-Pacific region [ 1 ]. One of the main challenges in diagnosing this condition is the high prevalence...
Laura Ramos, Cristina Reygosa, Marta Carrillo-Palau, Inmaculada Alonso-Abreu, Yanira González-Mendez, Raquel de la Barreda, Carla Amaral, Anjara Hernández, Federica Benítez-Zafra, Manuel Hernandez-Guerra
Dig Dis (2023) 41 (4): 574–580.
Published Online: 04 July 2023
... by the implementation of telehealth modalities in most inflammatory bowel disease (IBD) units. Aims: The aim of this study was to assess the efficacy, efficiency, patient satisfaction, and acceptability of using telephone consultation in an IBD unit. Methods: A prospective cohort study was performed in IBD patients who...
Marla C. Dubinsky, Alessandro Armuzzi, Krisztina B. Gecse, Thomas Ullman, Andrew G. Bushmakin, Marco DiBonaventura, Joseph C. Cappelleri, Susan B. Connelly, John C. Woolcott, Leonardo Salese
Dig Dis (2023) 41 (4): 604–614.
Published Online: 04 July 2023
.... First, Mayo subscores were mediators between the binary treatment variable (tofacitinib vs. placebo) and the eight Short Form-36 Health Survey (SF-36) domain scores as outcomes. Second, the four Inflammatory Bowel Disease Questionnaire (IBDQ) domain scores served as outcomes. Both models used data...
Benedetto Neri, Consuelo Russo, Michelangela Mossa, Francesco Giuseppe Martire, Aikaterini Selntigia, Roberto Mancone, Emma Calabrese, Giuseppe Rizzo, Caterina Exacoustos, Livia Biancone
Dig Dis (2023) 41 (5): 719–728.
Published Online: 30 June 2023
...Benedetto Neri; Consuelo Russo; Michelangela Mossa; Francesco Giuseppe Martire; Aikaterini Selntigia; Roberto Mancone; Emma Calabrese; Giuseppe Rizzo; Caterina Exacoustos; Livia Biancone Introduction: Inflammatory bowel disease (IBD) and endometriosis are chronic inflammatory diseases occurring...
Teodora Surdea-Blaga, Abdulrahman Ismaiel, Ayman Jaaouani, Daniel-Corneliu Leucuta, Abdalla Elsayed, Mohamed Ismaiel, Inès Ben Ameur, Nahlah Al Srouji, Stefan-Lucian Popa, Simona Grad, Dilara Ensar, Dan L. Dumitrascu
Dig Dis 1–12.
Published Online: 29 June 2023
... of inflammatory conditions. The role of adipokines in inflammatory bowel disease (IBD) has been evaluated in the current literature with conflicting results. The aim of this study was to evaluate adiponectin levels in IBD patients, including Crohn’s disease (CD) and ulcerative colitis (UC), compared to controls...
Dig Dis (2023) 41 (3): 396–404.
Published Online: 16 May 2023
...Lili You; Chenxiao Bai; Siyao Wang; Xiang Yu; Tiantian Wang; Min Lu; Chuyi Tan; Yuxia Guan Background: The prevalence of inflammatory bowel disease (IBD) is rapidly increasing in China. Beyond disease management, frailty is an important predictor of adverse outcomes in IBD patients, which has...
Johanna Maria Classen, Anna Muzalyova, Sandra Nagl, Carola Fleischmann, Alanna Ebigbo, Christoph Römmele, Helmut Messmann, Elisabeth Schnoy
Dig Dis (2022) 40 (6): 719–727.
Published Online: 29 November 2022
... impact on everyday life since then. In December 2020, the first vaccine against COVID-19 from BioNTech/Pfizer was approved for the first time. However, little is known about the immune response to vaccination in patients with inflammatory bowel disease (IBD) and immunomodulators or biologics. The aim...
Dig Dis (2022) 40 (6): 793–795.
Published Online: 27 January 2022
...Howard Faden Faecalibacterium and Roseburia are major producers of butyrate in the intestine. A reduced abundance of the organisms and a concurrent reduction in butyrate levels are associated with inflammatory bowel disease. firstname.lastname@example.org 5 10 2021 26 01 2022 27 1 2022...
Debora Compare, Costantino Sgamato, Olga Maria Nardone, Alba Rocco, Pietro Coccoli, Carmen Laurenza, Gerardo Nardone
Dig Dis (2022) 40 (1): 123–132.
Published Online: 18 January 2022
... and the most effective probiotic for different gastrointestinal conditions are still lacking. Here, we reviewed the studies on the use of probiotics in some diseases of relevant interest to gastroenterologists, such as Helicobacter pylori infection, irritable bowel syndrome, and inflammatory bowel disease. Key...
Dig Dis (2022) 40 (4): 506–514.
Published Online: 10 September 2021
... system, as well as related disease pathogenesis, and then provide a discussion focusing on the management and vaccination of patients who have inflammatory bowel disease (IBD) and GI cancer. The virus can affect the digestive system via binding to ACE2 receptors and subsequent gut microbiome dysbiosis...
Dig Dis (2022) 40 (3): 290–298.
Published Online: 31 May 2021
...Abhinav Mathur; Mairi H. McLean; Huan Cao; Mark A. Vickers Background: Functional hyposplenism is a recognized complication of several gastroenterological disorders, including coeliac and inflammatory bowel diseases, and is believed to contribute to the increased infection risk seen...
Tiago Leal, Margarida Gonçalves, Pedro Antunes, Dalila Costa, Sofia Mendes, João Bruno Soares, Ana Rebelo, Bruno Gonçalves, Bruno Arroja, Raquel Gonçalves
Dig Dis (2021) 39 (5): 496–501.
Published Online: 15 February 2021
...Tiago Leal; Margarida Gonçalves; Pedro Antunes; Dalila Costa; Sofia Mendes; João Bruno Soares; Ana Rebelo; Bruno Gonçalves; Bruno Arroja; Raquel Gonçalves Background: There is growing evidence about the relationship between sleep quality (SQ) and disease activity in inflammatory bowel disease (IBD...
Subject Area:Topic Article Package: Moksha , Topic Article Package: About COVID-19 and Nutrition , Topic Article Package: Coronavirus (COVID-19) , Gastroenterology
Richard H. Hunt, James E. East, Angel Lanas, Peter Malfertheiner, Jack Satsangi, Carmelo Scarpignato, Gwilym J. Webb
Dig Dis (2021) 39 (2): 119–139.
Published Online: 09 October 2020
... system. Summary: This review brings new clinically important information for the gastroenterologist. This includes: the mechanisms of tissue damage seen with the SARS-CoV-2 virus; the consequences of immunosuppression in patients with inflammatory bowel disease (IBD) and chronic liver disease...
Dig Dis (2021) 39 (3): 190–203.
Published Online: 17 September 2020
...Gabriele Dragoni; Tommaso Innocenti; Andrea Galli Background: Inflammatory bowel disease (IBD) is a chronically relapsing disease with a continuous need for proactive monitoring to decide appropriate treatments and follow-up strategies. To date, gastrointestinal endoscopy with histologic...
Stefan Reischl, Jasmin Troger, Moritz Jesinghaus, Atsuko Kasajima, Dirk Felix Wilhelm, Helmut Friess, Philipp-Alexander Neumann
Dig Dis (2020) 38 (5): 398–407.
Published Online: 20 March 2020
... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Crohn’s disease (CD) – as one of the inflammatory bowel diseases (IBD) – is a chronic inflammatory disorder...
Dig Dis (2020) 38 (6): 507–514.
Published Online: 05 March 2020
...Min Kyu Kang; Kyeong Ok Kim; Min Cheol Kim; Jung Gil Park; Byung Ik Jang Background and Aim: Recently, sarcopenia has been proposed as an additional risk factor of nonalcoholic fatty liver disease (NAFLD), and there have been no studies in patients with inflammatory bowel disease (IBD). We aimed...
Ray Lu, Thamer Kassim, Devashree Dave, Jagpal Singh Klair, Muhammad Ashfaq, Subhash Chandra, Arvind R. Murali
Dig Dis (2020) 38 (6): 484–489.
Published Online: 21 February 2020
... different institutions from -October 2016 to April 2019. Patients with familial colorectal cancer (CRC) syndromes were excluded. DY was calculated based on the proportion of abnormal colonoscopy defined as having inflammatory bowel disease (IBD), microscopic colitis (MC), advanced adenoma, or CRC. Results...